JP Patent

JP5948246B2 — Ｂｃｒ−ａｂｌ、ｃ−ｋｉｔ、ｄｄｒ１、ｄｄｒ２またはｐｄｇｆ−ｒのキナーゼ活性によって仲介される増殖性障害およびその他の病態の治療方法

Assigned to ノバルティス アーゲー · Expires 2016-07-06 · 10y expired

What this patent protects

Patent listed against nilotinib-hydrochloride.

Drugs covered by this patent

Patent Metadata

Patent number
JP5948246B2
Jurisdiction
JP
Classification
—
Expires
2016-07-06
Drug substance claim
No
Drug product claim
No
Assignee
ノバルティス アーゲー
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.